Timber Pharmaceuticals, Inc., a LEO Pharma company

Timber Pharmaceuticals, Inc. – a LEO Pharma company, was formed in January 2024 through the LEO Pharma’s acquisition of the assets of Timber Pharmaceuticals, Inc. The history of Timber as company goes back to 2019. Timber Pharmaceuticals was founded to develop treatments for unmet needs in medical dermatology and continues this mission today. Timber focuses on rare diseases or conditions of the skin for which there are no current treatments. Rare skin diseases are among the most neglected therapeutic areas in the pharmaceutical industry with few treatment options available to patients. Disclaimer: This site is intended for discussions about Timber Pharmaceuticals, Inc. – a LEO Pharma company and the various initiatives Timber Pharmaceuticals is involved in. Due to regulations, discussions about pharmaceutical products or investigational products are not allowed on this channel. All content must be factual and non-promotional. Timber Pharmaceuticals reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and the values of Timber Pharmaceuticals and LEO Pharma, including: - Profane or vulgar language - Insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc. - Commercial or political advertising - Copyright infringements, or any violation of the rights of external parties - automatically-generated content i.e. spam - Wrong/false statements. For more information about our social media principles, please visit https://leo-pharma.com/social-media-principles To view our privacy policy, go to https://www.leo-pharma.us/Home/Privacy.aspx